Consensus Moelis & Company

Equities

MC

US60786M1053

Market Closed - Nyse 04:00:02 2024-05-03 pm EDT 5-day change 1st Jan Change
51.58 USD +0.62% Intraday chart for Moelis & Company +3.68% -8.11%

Evolution of the average Target Price on Moelis & Company

Price target over the last 5 years

History of analyst recommendation changes

10.4eqUiUkIk-aUo-QEWCz9E30QvVCb7WD-5DAJbJ1qDIE.q77f4i5E8Yzg1JdvPVaKfTp43j3T2C6UhkRLG_shSMSRmOTKBz7ms-Lk3A~cb2f69cde814a17e8e253cbc8c1892b4
UBS Raises Moelis & Company Price Target to $47 From $45, Maintains Sell Rating MT
Banco Santander Hires DealMakers From Perella, William Blair, Moelis MT
UBS Trims Moelis & Company Price Target to $45 From $46, Maintains Sell Rating MT
Goldman Sachs Upgrades Moelis & Co. to Neutral From Sell, Adjusts Price Target to $58 From $53 MT
Goldman Sachs Raises Moelis & Co.'s Price Target to $47 From $41, Keeps Sell Rating MT
UBS Adjusts Moelis & Company Price Target to $32 From $30, Maintains Sell Rating MT
UBS Adjusts Moelis Price Target to $30 From $29, Maintains Sell Rating MT
UBS Adjusts Moelis & Company Price Target to $29 From $32, Maintains Sell Rating MT
JPMorgan Adjusts Moelis & Co.'s Price Target to $56 From $45, Keeps Neutral Rating MT
Goldman Sachs Adjusts Moelis & Co.'s Price Target to $40 From $35, Keeps Sell Rating MT
Morgan Stanley Adjusts Price Target on Moelis to $39 From $29, Maintains Underweight Rating MT
UBS Adjusts Price Target on Moelis to $32 From $27, Maintains Sell Rating MT
Keefe, Bruyette & Woods Adjusts Price Target on Moelis & Company to $37 From $40, Keeps Underperform Rating MT
Morgan Stanley Adjusts Price Target on Moelis & Company to $29 From $30, Keeps Underweight Rating MT
UBS Lowers Moelis & Co.'s Price Target to $27 From $30, Keeps Sell Rating MT
Goldman Sachs Adjusts Price Target on Moelis & Company to $36 From $40, Maintains Sell Rating MT
Goldman Sachs Adjusts Price Target on Moelis & Company to $42 From $38, Maintains Sell Rating MT
Goldman Sachs Downgrades Moelis & Company to Sell From Neutral, Adjusts Price Target to $37 From $40 MT
UBS Adjusts Moelis & Company Price Target to $30 From $32, Maintains Sell Rating MT
UBS Adjusts Moelis & Company Price Target to $32 From $35, Maintains Sell Rating MT
Keefe, Bruyette & Woods Downgrades Moelis & Company to Underperform Rating From Market Perform, Adjusts Price Target to $37 From $40 MT
Goldman Sachs Adjusts Moelis & Co.'s Price Target to $38 from $43, Maintains Neutral Rating MT
UBS Downgrades Moelis & Company to Sell From Neutral, Adjusts Price Target to $35 From $43 MT
UBS Adjusts Moelis & Company Price Target to $43 From $40, Maintains Neutral Rating MT
Morgan Stanley Downgrades Moelis & Company to Underweight From Equal Weight, Adjusts Price Target to $36 From $53 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
51.58 USD
Average target price
52 USD
Spread / Average Target
+0.81%
High Price Target
57 USD
Spread / Highest target
+10.51%
Low Price Target
47 USD
Spread / Lowest Target
-8.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moelis & Company

UBS
Goldman Sachs
JPMorgan Chase
Morgan Stanley
Keefe, Bruyette & Woods
Wolfe Research
Piper Sandler
JMP Securities
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. MC Stock
  4. Consensus Moelis & Company